In LPS challenge, PAI-1 inhibition reduced mortality by reducing hypercoagulation, whereas, in a pneumonia model, PAI-1 deficiency attenuated neutrophil responsiveness in the lungs and increased mortality [52,53]. Here, SERPINE1 is linked to pneumonia.